Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma

NCT03341806 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
GBM

Interventions

DRUG: Avelumab
COMBINATION_PRODUCT: MRI-guided LITT therapy

Sponsor

Icahn School of Medicine at Mount Sinai